BACKGROUND AND AIM: Elevated serum tumor necrosis factor-α (TNF-α) concentra-tion and a polymorphism of the TNF-α gene at the position -308 in the promoter region are associated with obstructive sleep apnea-hypopnea syndrome (OSAHS). We aimed to determine the association of this polymorphism with OSAHS in Greek patients. PATIENTS AND METHODS: A blood sample was obtained from 220 patients clinicaly diagnosed with OSAHS and 319 normal controls. TNF-α genotype was determined from nucleus-containing cells from whole blood using a PCR method. RESULTS: The results demonstrated that the distribution of alleles was significantly dif-ferent when comparing the OSAHS patients group to the healthy controls. The appearance of AA (p=0.04) and AG (p<0.001) genotypes was significantly greater in OSAHS patients (8.6% and 32.7%, respectively) compared to the healthy control group (4.4% and 26.3%, respectively). Correspondingly, the appearance of the GG genotype was significantly lower in OSAHS patients compared to healthy controls (53.6% vs 69.3%). The A and G allele appeared at a frequency of 27.5% and 72.5% respectively in the OSAHS groups, and 17.6% and 82.4% in the control group respectively. CONCLUSIONS: The distribution of genotypes and alleles of the single nucleotide polymorphism of TNF-α (-308) of OSAHS patients varies from healthy controls.
BACKGROUND AND AIM: Elevated serum tumor necrosis factor-α (TNF-α) concentra-tion and a polymorphism of the TNF-α gene at the position -308 in the promoter region are associated with obstructive sleep apnea-hypopnea syndrome (OSAHS). We aimed to determine the association of this polymorphism with OSAHS in Greek patients. PATIENTS AND METHODS: A blood sample was obtained from 220 patients clinicaly diagnosed with OSAHS and 319 normal controls. TNF-α genotype was determined from nucleus-containing cells from whole blood using a PCR method. RESULTS: The results demonstrated that the distribution of alleles was significantly dif-ferent when comparing the OSAHSpatients group to the healthy controls. The appearance of AA (p=0.04) and AG (p<0.001) genotypes was significantly greater in OSAHSpatients (8.6% and 32.7%, respectively) compared to the healthy control group (4.4% and 26.3%, respectively). Correspondingly, the appearance of the GG genotype was significantly lower in OSAHSpatients compared to healthy controls (53.6% vs 69.3%). The A and G allele appeared at a frequency of 27.5% and 72.5% respectively in the OSAHS groups, and 17.6% and 82.4% in the control group respectively. CONCLUSIONS: The distribution of genotypes and alleles of the single nucleotide polymorphism of TNF-α (-308) of OSAHSpatients varies from healthy controls.
Authors: E Louis; D Franchimont; A Piron; Y Gevaert; N Schaaf-Lafontaine; S Roland; P Mahieu; M Malaise; D De Groote; R Louis; J Belaiche Journal: Clin Exp Immunol Date: 1998-09 Impact factor: 4.330
Authors: Victoria Alvarez; Ignacio F Mata; Pelayo González; Carlos H Lahoz; Carmen Martínez; Joaquín Peña; Luis M Guisasola; Eliecer Coto Journal: Am J Med Genet Date: 2002-07-08
Authors: Brieann C Satterfield; Jonathan P Wisor; Stephanie A Field; Michelle A Schmidt; Hans P A Van Dongen Journal: Brain Behav Immun Date: 2014-12-24 Impact factor: 7.217
Authors: Matthew D Rockstrom; Liangyu Chen; Ping Taishi; Joseph T Nguyen; Cody M Gibbons; Sigrid C Veasey; James M Krueger Journal: Sleep Med Rev Date: 2017-11-17 Impact factor: 11.609